The Novo Nordisk Foundation is granting USD 46.1m (DKK 290m) to the new international research center, while ramping up its global activities.
The goal is to expand the Danish life science ecosystem by creating global access to leading scientists, technologies and training programs. This is why the commercial foundation, with a net worth of USD 71.5bn (DKK 450bn), plans to establish several similar centers in the coming years, says CEO at the Novo Nordisk Foundation Mads Krogsgaard Thomsen.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.